Try our Advanced Search for more refined results
Life Sciences - January, 2006
35 articles
- In Blow To Sanofi, Judge Refuses To Bar Allegra Generics
- Asbestos Companies Eye Chapter 11 Emergence
- Sonnenschein Hires Seasoned Chadbourne Partner
- Curbed At Home, India's Generic Makers Go Overseas
- Emory Fires Patent Suit At Biotech Co, Former Exec
- Tyco Suffers Again As Court Upholds $64.5M Judgment
- Tyco Shells Out $330M In Masimo Settlement
- Besieged Medtronic Settles Heart Patent Dispute
- Bristol-Myers Braces For Blow In Class Action Suit
- QLT Loses Again To Takeda Abbott In Cancer Drug Clash
- Shire OKs Generic Version of Blockbuster Drug
- Teva's Latest ANDA Draws Fire
- Rare Victory For Generic Drug Industry In Patent Ruling
- Medtronic In Hot Water Again Over Spine Patents
- Biotech Giants Find Cooperation More Lucrative
- SOX Whistle-Blowing Rules Don't Apply Outside U.S.
- Court Upholds Pfizer Patent For Norvasc
- Former Top Lawyer to Pay $3M In Fraud Settlement
- Genetics Companies End Patent Dispute Over HPV Test
- Kaye Scholer Lures Away Howrey Partners
- Drug Makers Nervously Eye High Court On Generics
- SEC Eyes Hedge Fund's Influence In Merger Talks
- SEC Probes Drug Trial Firm Accused Of Recklessness
- Westward Bound, Connolly Bove Opens New L.A. Office
- Federal Circuit Rules On Lucrative DVR Patents
- Cephalon, Mylan Settle Patent Dispute Over Provigil
- Supreme Court Eyes Glaxo's Paxil Appeal
- Eli Lilly Loses Case Brought By Tiny Biotech Company
- In Blow to Knight Ridder, Judge Refuses to Dismiss Case
- Repligen Seeks To Block Launch Of Bristol-Myers Drug
- Damages In Little-Known Biotech Suit Reach Record Level
- Briefs In LabCorp Case Split Over Business Methods
- Generics Maker Suffers Blow In Eye Drug Ruling
- Baxter Launches At-Risk Generic During Appeal
- Patent Suits Break Decade-Old Trend, Drop In '05